LOTUSEYE

Lotus Eye Hospital And Institute Share PriceLotus Eye Hospital and Institute

₹86.75
-1.35 (-1.53%)
As on 10 December, 2023 | 22:06 BSE: 532998 NSE: LOTUSEYEISIN: INE947I01017

Lotus Eye Hospital And Institute Performance

Day Range

  • Low 86.15
  • High 88.95
₹ 86.75

52 Week Range

  • Low 55.20
  • High 111.00
₹ 86.75
  • Open Price88.95
  • Previous Close88.10
  • Volume7974

Start SIP in Lotus Eye Hospital and Institute

Start SIP

Lotus Eye Hospital And Institute Share Price

  • Over 1 Month 0.58%
  • Over 3 Month -3.5%
  • Over 6 Month 10.02%
  • Over 1 Year 2.12%

Lotus Eye Hospital And Institute Key Statistics

P/E Ratio 44.7
PEG Ratio -11.8
Market Cap Cr 180
Price to Book Ratio 3.1
EPS 2
Dividend 0.6
Relative Strength Index 45.07
Money Flow Index 33.81
MACD Signal 0.4
Average True Range 5.19

Lotus Eye Hospital And Institute Investment Rating

  • Master Rating:
  • Lotus Eye Hospital And Institute has an operating revenue of Rs. 48.60 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 12% is healthy, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 8% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -19% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lotus Eye Hospital and Institute Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 13131112121211
Operating Expenses Qtr Cr 1110101010109
Operating Profit Qtr Cr 2212221
Depreciation Qtr Cr 1111111
Interest Qtr Cr 0000000
Tax Qtr Cr 0100000
Net Profit Qtr Cr 1111111
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 4840
Operating Expenses Annual Cr 3933
Operating Profit Annual in Cr 86
Depreciation Cr 33
Interest Annual Cr 00
Tax Annual Cr 21
Net Profit Annual Cr 43
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 44
Cash from Investing Activity Annual Cr -4-4
Cash from Financing Annual Activity Cr -2-2
Net Cash Flow Annual Cr -1
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 5855
Fixed Assets Annual Cr 4444
Total Non Current Assets Annual Cr 4849
Total Current Assets Annual Cr 1513
Total Assets Annual Cr 6362
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 2826
ROE Annual % 75
ROCE Annual % 108
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1917
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Lotus Eye Hospital And Institute Technicals

EMA & SMA

Current Price
₹86.75
-1.35 (-1.53%)
pointer
  • Bullish Moving Average
  • ___
  • 4
  • Bearish Moving Average
  • ___
  • 12
  • 20 Day
  • ₹89.17
  • 50 Day
  • ₹88.45
  • 100 Day
  • ₹86.56
  • 200 Day
  • ₹82.19
  • 20 Day
  • ₹91.22
  • 50 Day
  • ₹87.49
  • 100 Day
  • ₹88.93
  • 200 Day
  • ₹79.64

Lotus Eye Hospital And Institute Resistance and Support

PIVOT
₹87.29
Resistance
First Resistance 88.42
Second Resistance 90.08
Third Resistance 91.22
RSI 45.07
MFI 33.81
MACD Single Line 0.40
MACD -0.33
Support
First Resistance 85.62
Second Resistance 84.48
Third Resistance 82.82

Lotus Eye Hospital And Institute Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 12,399 791,552 63.84
Week 23,592 1,525,918 64.68
1 Month 88,765 4,248,277 47.86
6 Month 40,976 2,807,259 68.51

Lotus Eye Hospital And Institute Result Highlights

Lotus Eye Hospital and Institute Synopsis

NSE-Medical-Hospitals

Lotus Eye Hospital belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 47.04 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2023. Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783.
Market Cap 180
Sales 49
Shares in Float 0.87
No of funds
Yield 0.58
Book Value 3.13
U/D Vol ratio 0.3
LTDebt / Equity
Alpha 0.01
Beta 0.87

Lotus Eye Hospital and Institute

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 57.58%58.43%58.17%58.14%
Foreign Portfolio Investors
Individual Investors 22.95%21.14%21.63%21.8%
Others 19.47%20.43%20.2%20.06%

Lotus Eye Hospital and Institute Management

Name Designation
Dr. Kavetha Sundaramoorthy Chairman
Ms. Sangeetha Sundaramoorthy Managing Director
Dr. K S Ramalingam Executive Director & CEO
Mr. D R Kaarthikeyan Director
Dr. Yogesh Shah Director
CA. R Subramanian Director
CA. M Alagiriswamy Director
Dr. S Natesan Director

Lotus Eye Hospital And Institute Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lotus Eye Hospital And Institute Corporate Action

Date Purpose Remarks
2023-08-14 Quarterly Results
2023-05-24 Audited Results & Dividend
2023-02-13 Quarterly Results
2022-11-14 Audited Results
2022-08-09 Quarterly Results
Date Purpose Remarks
2022-09-10 FINAL Rs.0.50 per share(5%)Final Dividend

Lotus Eye Hospital and Institute FAQs

What is Share Price of Lotus Eye Hospital and Institute ?

Lotus Eye Hospital and Institute share price is ₹86 As on 10 December, 2023 | 21:52

What is the Market Cap of Lotus Eye Hospital and Institute ?

The Market Cap of Lotus Eye Hospital and Institute is ₹180.4 Cr As on 10 December, 2023 | 21:52

What is the P/E ratio of Lotus Eye Hospital and Institute ?

The P/E ratio of Lotus Eye Hospital and Institute is 44.7 As on 10 December, 2023 | 21:52

What is the PB ratio of Lotus Eye Hospital and Institute ?

The PB ratio of Lotus Eye Hospital and Institute is 3.1 As on 10 December, 2023 | 21:52

Q2FY23